The US Food & Drug Administration has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India for Amphetamine Sulfate Tablets USP 5 mg and 10 mg.
Tuesday, 6 August 2019
Indiabulls Real Estate Clarifies on Embassy Group Deal
The US Food & Drug Administration has approved the abbreviated new drug application filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India for Amphetamine Sulfate Tablets USP 5 mg and 10 mg.
Subscribe to:
Post Comments (Atom)
Trends On SGX Nifty Indicate A Positive Opening For The Broader Index In India
Trends on SGX Nifty indicate a positive opening for the broader index in India, with a 31.5 points gain or 0.25 percent. The Nifty future...
-
Prime Minister Narendra Modi-led National Democratic Alliance government's sixth and final budget before the polls due in April-May i... -
Maruti Suzuki India share price added 1.5 percent in the early trade on December 17 after foreign research house Bank of America Merrill ... -
Shares of Bandhan Bank rallied nearly 9 percent intraday on October 15 ahead of addition in the MSCI index tomorrow. Gruh Finance also g...
No comments:
Post a Comment